
Sign up to save your podcasts
Or


The FDA approval of TAVR for asymptomatic AS, digital health, subcutaneous vs transvenous ICD, and cryptogenic stroke in young adults are discussed by John Mandrola, MD.
This podcast is intended for healthcare professionals only.
To read a partial transcript or to comment, visit:
https://www.medscape.com/twic
I FDA announces approval for TAVR in pts with asymptomatic AS
II PPG that Can Distinguish source of Tachycardia
III PRAETORIAN -XL trial
IV Stroke in Young People
You may also like:
The Bob Harrington Show with the Stephen and Suzanne Weiss Dean of Weill Cornell Medicine, Robert A. Harrington, MD. https://www.medscape.com/author/bob-harrington
Questions or feedback, please contact [email protected]
By Medscape4.9
862862 ratings
The FDA approval of TAVR for asymptomatic AS, digital health, subcutaneous vs transvenous ICD, and cryptogenic stroke in young adults are discussed by John Mandrola, MD.
This podcast is intended for healthcare professionals only.
To read a partial transcript or to comment, visit:
https://www.medscape.com/twic
I FDA announces approval for TAVR in pts with asymptomatic AS
II PPG that Can Distinguish source of Tachycardia
III PRAETORIAN -XL trial
IV Stroke in Young People
You may also like:
The Bob Harrington Show with the Stephen and Suzanne Weiss Dean of Weill Cornell Medicine, Robert A. Harrington, MD. https://www.medscape.com/author/bob-harrington
Questions or feedback, please contact [email protected]

1,877 Listeners

319 Listeners

544 Listeners

708 Listeners

502 Listeners

167 Listeners

14 Listeners

16 Listeners

3,384 Listeners

138 Listeners

1,143 Listeners

65 Listeners

521 Listeners

367 Listeners

61 Listeners

25 Listeners

7 Listeners

259 Listeners

440 Listeners

272 Listeners